Use of F-18 Flortaucipir for Mapping Tau Pathology

Course overview

UAN: 0018-0000-21-210-H01-P & T RELEASE: 07/12/2021 EXPIRE: 07/12/2024 CREDITS: 1.25 LEARNING OBJECTIVES: 1. Describe the application of flortaucipir F 18 Tauvid imaging in Alzheimers disease 2. Distinguish flortaucipir F 18 features in comparison with amyloid imaging NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.